# Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis

> **NCT01024777** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 40 (actual)

## Conditions studied

- Multiple Sclerosis
- Vitamin D Deficiency

## Interventions

- **DRUG:** Cholecalciferol
- **DRUG:** Cholecalciferol

## Key facts

- **NCT ID:** NCT01024777
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01024777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01024777, "Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01024777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*